[1]
S. Ammari and N. Ibrahim, “Golimumab-associated myocarditis with progressive eosinophilia after route switch in rheumatoid arthritis”, EJCRIM, vol. 13, no. 6, Jun. 2026, doi: 10.12890/2026_006759.